Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.

Article  CAS  PubMed  PubMed Central  Google Scholar 

WuF, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265–9.

Article  Google Scholar 

RahimiA, Mirzazadeh A, Tavakolpour S. Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection. Genomics. 2021;113(4):1221–32.

Article  Google Scholar 

Zhang ZM, Qu X. Coronavirus disease 2019 (COVID-19): a clinical update. Front Med. 2020;14(2):126–35.

Article  PubMed  PubMed Central  Google Scholar 

ChannappanavarR, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39(5):529–39.

Article  PubMed  Google Scholar 

Tahaghoghi-HajghorbaniS, Zafari P, Masoumi E, Rajabinejad M, Jafari-Shakib R, Hasani B, et al. The role of dysregulated immune responses in COVID-19 pathogenesis. Virus Res. 2020;290:198197.

Article  PubMed  Google Scholar 

MouroV, Fischer A. Dealing with a mucosal viral pandemic: lessons from COVID-19 vaccines. Mucosal Immunol. 2022;15(5):584–94.

PubMed  Google Scholar 

KumariM, Lu RM, Li MC, Huang JL, Hsu FF, Ko SH, et al. A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies. J Biomed Sci. 2022;29(1):68.

Article  PubMed  Google Scholar 

MulliganMJ, Lyke KE, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020;586(7827):589–93.

Article  PubMed  Google Scholar 

Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603–15.

Article  CAS  PubMed  Google Scholar 

SelfWH, Tenforde MW, Rhoads JP, Gaglani M, Ginde AA, Douin DJ, et al. Comparative effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) vaccines in preventing COVID-19 hospitalizations among adults without Immunocompromising Conditions - United States, March-August 2021. MMWR Morb Mortal Wkly Rep. 2021;70(37):1337–43.

PubMed  Google Scholar 

HiltyMP, Keiser S, Wendel Garcia PD, Moser A, Schuepbach RA, RISC-19-ICU Investigators for Switzerland. mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland. Intensive Care Med. 2022;48(3):362–5.

Article  PubMed  Google Scholar 

TenfordeMW, Self WH, Adams K, Gaglani M, Ginde AA, McNeal T, et al. Association between mRNA vaccination and COVID-19 hospitalization and disease severity. JAMA. 2021;326(21):2043–54.

Article  PubMed  Google Scholar 

Thomas SJ, Moreira ED, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N Engl J Med. 2021;385(19):1761–73.

Article  CAS  PubMed  Google Scholar 

DongY, Dai T, Wei Y, Zhang L, Zheng M, Zhou F. A systematic review of SARS-CoV-2 vaccine candidates. Signal Transduct Target Ther. 2020;5(1):1–14.

Google Scholar 

Xiao L, Yu W, Shen L, Yan W, Qi J, Hu T. Mucosal SARS-CoV-2 nanoparticle vaccine based on mucosal adjuvants and its immune effectiveness by intranasal administration. ACS Appl Mater Interfaces. 2023;15(30):35895–905.

Article  CAS  PubMed  Google Scholar 

Miquel-Clopés A, Bentley EG, Stewart JP, Carding SR. Mucosal vaccines and technology. Clin Exp Immunol. 2019;196(2):205–14.

Article  PubMed  PubMed Central  Google Scholar 

Morens DM, Taubenberger JK, Fauci AS. Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses. Cell Host Microbe. 2023;31(2):146–57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

BrickerTL, Darling TL, Hassan AO, Harastani HH, Soung A, Jiang X, et al. A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters. Cell Rep. 2021;36(9):109400.

PubMed  Google Scholar 

van FischerRJ N, Adney DR, Yinda CK, Port JR, Holbrook MG, et al. ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7. Nat Commun. 2021;12(1):5868.

Article  Google Scholar 

vanDoremalen N, Purushotham JN, Schulz JE, Holbrook MG, Bushmaker T, Carmody A, et al. Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models. Sci Transl Med. 2021;13(578):eabh0755.

Article  CAS  Google Scholar 

Kim SH, Jang YS. Recent insights into cellular crosstalk in respiratory and gastrointestinal mucosal immune systems. Immune Netw. 2020;20(1):e44.

Article  PubMed  PubMed Central  Google Scholar 

Azegami T, Yuki Y, Kiyono H. Challenges in mucosal vaccines for the control of infectious diseases. Int Immunol. 2014;26(9):517–28.

Article  CAS  PubMed  Google Scholar 

Gerdts V, Mutwiri GK, Tikoo SK, Babiuk LA. Mucosal delivery of vaccines in domestic animals. Vet Res. 2006;37(4):487–510.

Article  CAS  PubMed  Google Scholar 

MayerL, Walker WA. Chapter 1 - Development and physiology of mucosal defense: an introduction. In: Mestecky J, Lamm ME, McGhee JR, Bienenstock J, Mayer L, Strober W, editors. Mucosal immunology (Third Edition). Burlington: Academic; 2005. pp. 5–18.

Google Scholar 

Boyton RJ, Openshaw PJ. Pulmonary defences to acute respiratory infection. Br Med Bull. 2002;61(1):1–12.

Article  CAS  PubMed  Google Scholar 

Linden SK, Sutton P, Karlsson NG, Korolik V, McGuckin MA. Mucins in the mucosal barrier to infection. Mucosal Immunol. 2008;1(3):183–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iwasaki A, Foxman EF, Molony RD. Early local immune defences in the respiratory tract. Nat Rev Immunol. 2017;17(1):7–20.

Article  CAS  PubMed  Google Scholar 

Elphick DA, Mahida YR. Paneth cells: their role in innate immunity and inflammatory disease. Gut. 2005;54(12):1802–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cesta MF. Normal structure, function, and histology of mucosa-associated lymphoid tissue. Toxicol Pathol. 2006;34(5):599–608.

Article  PubMed  Google Scholar 

Tschernig T, Pabst R. Bronchus-associated lymphoid tissue (BALT) is not present in the normal adult lung but in different diseases. Pathobiology. 2000;68(1):1–8.

Article  CAS  PubMed  Google Scholar 

Brandtzaeg P, Pabst R. Let’s go mucosal: communication on slippery ground. Trends Immunol. 2004;25(11):570–7.

Article  CAS  PubMed  Google Scholar 

LiY, Jin L, Chen T. The Effects of Secretory IgA in the Mucosal Immune System. BioMed Res Int. 2020:2032057.

Chodirker WB, Tomasi TB. Gamma-globulins:. Quantitative relationships in human serum and nonvascular fluids. Science. 1963;142(3599):1080–1.

Article  CAS  PubMed  Google Scholar 

Pilapitiya D, Wheatley AK, Tan HX. Mucosal vaccines for SARS-CoV-2: triumph of hope over experience. eBioMedicine. 2023;92:104585.

Article  CAS  PubMed  PubMed Central  Google Scholar 

NurkicJ, Numanovic F, Arnautalic L, Tihic N, Halilovic D, Jahic M. Diagnostic significance of reduced IgA in children. Med Arch Sarajevo Bosnia Herzeg. 2014;68(5):381–3.